{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:44:30Z","timestamp":1791229470027,"version":"4.1.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Pediatr Endocrinol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1687-9856-2014-10","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T02:18:23Z","timestamp":1402971503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Pediatric Graves\u2019 disease: management in the post-propylthiouracil Era"],"prefix":"10.1186","volume":"2014","author":[{"given":"Scott A","family":"Rivkees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,16]]},"reference":[{"key":"353_CR1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1530\/EJE-07-0877","volume":"158","author":"M Abraham-Nordling","year":"2008","unstructured":"Abraham-Nordling M, Torring O, Lantz M, Hallengren B, Ohrling H, Lundell G, Calissendorff J, J\u00f6rneskog G, Wallin G: Incidence of hyperthyroidism in Stockholm, Sweden, 2003\u20132005. Eur J Endocrinol\/Eur Fed Endocr Soc. 2008, 158: 823-827.","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"key":"353_CR2","unstructured":"Conference Proceeding: Hepatic Toxicity Following Treatment for Pediatric Graves\u2019 Disease Meeting: October 28, 2008. Conference Proceeding: Hepatic Toxicity Following Treatment for Pediatric Graves\u2019 Disease Meeting: October 28, 2008, http:\/\/bpca.nichd.nih.gov\/outreach\/index.cfm . 2009. (Accessed January 14, 2009, at http:\/\/bpca.nichd.nih.gov\/outreach\/index.cfm .)"},{"key":"353_CR3","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1089\/thy.2007.0072","volume":"17","author":"J Smith","year":"2007","unstructured":"Smith J, Brown RS: Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves' disease treated using antithyroid medication. Thyroid. 2007, 17: 1103-1107.","journal-title":"Thyroid"},{"key":"353_CR4","first-page":"3767","volume":"83","author":"SA Rivkees","year":"1998","unstructured":"Rivkees SA, Sklar C, Freemark M: Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metabol. 1998, 83: 3767-3776.","journal-title":"J Clin Endocrinol Metabol"},{"issue":"Suppl 1","key":"353_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000067837","volume":"59","author":"AP Weetman","year":"2003","unstructured":"Weetman AP: Grave's disease 1835\u20132002. Horm Res. 2003, 59 (Suppl 1): 114-118.","journal-title":"Horm Res"},{"key":"353_CR6","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1001\/jama.1983.03340150084036","volume":"250","author":"EM Chapman","year":"1983","unstructured":"Chapman EM: History of the discovery and early use of radioactive iodine. JAMA. 1983, 250: 2042-2044.","journal-title":"JAMA"},{"key":"353_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMra042972","volume":"352","author":"DS Cooper","year":"2005","unstructured":"Cooper DS: Antithyroid drugs. N Engl J Med. 2005, 352: 905-917.","journal-title":"N Engl J Med"},{"key":"353_CR8","first-page":"1","volume-title":"Functional Endocrinology: from Birth to Adolescence","author":"SE Talbot NB","year":"1952","unstructured":"Talbot NB SE, McArthur JW, Crawford JD: Functional Endocrinology: from Birth to Adolescence. 1952, Cambridge: Harvard University Press, 1-51."},{"key":"353_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0889-8529(05)70308-X","volume":"27","author":"DS Cooper","year":"1998","unstructured":"Cooper DS: Antithyroid drugs for the treatment of hyperthyroidism caused by Graves' disease. Endocrinol Metab Clin North Am. 1998, 27: 225-247.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"353_CR10","volume-title":"Int J Pediatr Endocrinol","author":"SA Rivkees","year":"2010","unstructured":"Rivkees SA: 63 Years and 715 Days to the \u201cBoxed Warning\u201d: Unmasking of the Propylthiouracil Problem. Int J Pediatr Endocrinol. 2010, 2010: Article ID 658267, 3 pages, 2010. doi:10.1155\/2010\/658267"},{"key":"353_CR11","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1056\/NEJMc0809750","volume":"360","author":"SA Rivkees","year":"2009","unstructured":"Rivkees SA, Mattison DR: Ending propylthiouracil-induced liver failure in children. N Engl J Med. 2009, 360: 1574-1575.","journal-title":"N Engl J Med"},{"key":"353_CR12","doi-asserted-by":"publisher","first-page":"132041","DOI":"10.1186\/1687-9856-2009-132041","volume":"2009","author":"SA Rivkees","year":"2009","unstructured":"Rivkees SA, Mattison DR: Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use. Int J Pediatr Endocrinol. 2009, 2009: 132041-","journal-title":"Int J Pediatr Endocrinol"},{"key":"353_CR13","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/lt.20204","volume":"10","author":"MW Russo","year":"2004","unstructured":"Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P: Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl. 2004, 10: 1018-1023.","journal-title":"Liver Transpl"},{"key":"353_CR14","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1210\/jc.2006-2135","volume":"92","author":"H Nakamura","year":"2007","unstructured":"Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N: Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab. 2007, 92: 2157-2162.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR15","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/00007611-199509000-00018","volume":"88","author":"WC Nicholas","year":"1995","unstructured":"Nicholas WC, Fischer RG, Stevenson RA, Bass JD: Single daily dose of methimazole compared to every 8\u00a0hours propylthiouracil in the treatment of hyperthyroidism. South Med J. 1995, 88: 973-976.","journal-title":"South Med J"},{"key":"353_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/thy.2006.0193","volume":"17","author":"H Sato","year":"2007","unstructured":"Sato H, Harada S, Yokoya S, Tanaka T, Asayama K, Mori M, Sasaki N: Treatment for childhood-onset Graves' disease in Japan: results of a nationwide questionnaire survey of pediatric endocrinologists and thyroidologists. Thyroid. 2007, 17: 67-72.","journal-title":"Thyroid"},{"key":"353_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2265.2005.02415.x","volume":"64","author":"A Cassio","year":"2006","unstructured":"Cassio A, Corrias A, Gualandi S, Tato' L, Cesaretti G, Volta C, Weber G, Bona G, Cappa M, Bal M, Bellone J, Cicognani A: Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis: results of a collaborative study. Clin Endocrinol (Oxf). 2006, 64: 53-57.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"353_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2165\/00128072-200305020-00003","volume":"5","author":"J Dotsch","year":"2003","unstructured":"Dotsch J, Rascher W, Dorr HG: Graves disease in childhood: a review of the options for diagnosis and treatment. Paediatr Drugs. 2003, 5: 95-102.","journal-title":"Paediatr Drugs"},{"key":"353_CR19","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1515\/JPEM.2000.13.7.879","volume":"13","author":"J Dotsch","year":"2000","unstructured":"Dotsch J, Siebler T, Hauffa BP, Doeker B, Andler W, Bettendorf M, Heinrich U, Gohlke B, Albers N, Willgerodt H, Kiess W: Diagnosis and management of juvenile hyperthyroidism in Germany: a retrospective multicenter study. J Pediatric Endocrinol. 2000, 13: 879-885.","journal-title":"J Pediatric Endocrinol"},{"key":"353_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1515\/JPEM.2005.18.6.597","volume":"18","author":"AH Slyper","year":"2005","unstructured":"Slyper AH, Wyatt D, Boudreau C: Effective methimazole dose for childhood Grave's disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery. J Pediatr Endocrinol Metab. 2005, 18: 597-602.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"353_CR21","first-page":"CD003420","volume":"2","author":"P Abraham","year":"2005","unstructured":"Abraham P, Avenell A, Watson WA, Park CM, Bevan JS: Antithyroid drug regimen for treating Graves' hyperthyroidism. Cochrane Database Syst Rev. 2005, 2: CD003420-","journal-title":"Cochrane Database Syst Rev"},{"key":"353_CR22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1530\/eje.1.02169","volume":"154","author":"S Razvi","year":"2006","unstructured":"Razvi S, Vaidya B, Perros P, Pearce SH: What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves' disease. Eur J Endocrinol\/Eur Fed Endocr Soc. 2006, 154: 783-786.","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"key":"353_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.7326\/0003-4819-98-1-26","volume":"98","author":"DS Cooper","year":"1983","unstructured":"Cooper DS, Goldminz D, Levin AA, Ladenson PW, Daniels GH, Molitch ME, Ridgway EC: Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med. 1983, 98: 26-29.","journal-title":"Ann Intern Med"},{"key":"353_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4158\/EP.8.3.222","volume":"8","author":"KA Woeber","year":"2002","unstructured":"Woeber KA: Methimazole-induced hepatotoxicity. Endocr Pract. 2002, 8: 222-224.","journal-title":"Endocr Pract"},{"key":"353_CR25","doi-asserted-by":"publisher","first-page":"176970","DOI":"10.1186\/1687-9856-2010-176970","volume":"2010","author":"SA Rivkees","year":"2010","unstructured":"Rivkees SA, Stephenson K, Dinauer C: Adverse events associated with methimazole therapy of graves' disease in children. Int J Pediatr Endocrinol. 2010, 2010: 176970-","journal-title":"Int J Pediatr Endocrinol"},{"key":"353_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1089\/thy.2005.15.292","volume":"15","author":"J Tajiri","year":"2005","unstructured":"Tajiri J, Noguchi S: Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy?. Thyroid. 2005, 15: 292-297.","journal-title":"Thyroid"},{"key":"353_CR27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1365-2265.2004.02029.x","volume":"60","author":"L Harper","year":"2004","unstructured":"Harper L, Chin L, Daykin J, Allahabadia A, Heward J, Gough SC, Savage CO, Franklyn JA: Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease. Clin Endocrinol (Oxf). 2004, 60: 671-675.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"353_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/ard.61.1.90","volume":"61","author":"M Guma","year":"2002","unstructured":"Guma M, Olive A, Juan M, Salinas I: ANCA antibodies in Graves' disease. Ann Rheum Dis. 2002, 61: 90-91.","journal-title":"Ann Rheum Dis"},{"key":"353_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/08916930400022673","volume":"38","author":"A Radice","year":"2005","unstructured":"Radice A, Sinico RA: Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity. 2005, 38: 93-103.","journal-title":"Autoimmunity"},{"issue":"Suppl 4","key":"353_CR30","first-page":"S1295","volume":"85","author":"P Poomthavorn","year":"2002","unstructured":"Poomthavorn P, Mahachoklertwattana P, Tapaneya-Olarn W, Chuansumrit A, Chunharas A: Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease. J Med Assoc Thai. 2002, 85 (Suppl 4): S1295-S1301.","journal-title":"J Med Assoc Thai"},{"key":"353_CR31","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5414\/CNP63437","volume":"63","author":"M Fujieda","year":"2005","unstructured":"Fujieda M, Suzuki K, Sato H, Hattori M, Wada N, Tsuchiya M, Okamoto N, Murata T, Matsudaira M, Shimizu M, Ohta K, Naruse K, Sugihara S, Wakiguchi H: Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies (MPO-ANCA) in childhood onset Graves' disease treated with propylthiouracil. Clin Nephrol. 2005, 63: 437-445.","journal-title":"Clin Nephrol"},{"key":"353_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00002281-199801000-00007","volume":"10","author":"PA Merkel","year":"1998","unstructured":"Merkel PA: Drugs associated with vasculitis. Curr Opin Rheumatol. 1998, 10: 45-50.","journal-title":"Curr Opin Rheumatol"},{"key":"353_CR33","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1210\/jcem-60-5-1019","volume":"60","author":"JI Hamburger","year":"1985","unstructured":"Hamburger JI: Management of hyperthyroidism in children and adolescents. J Clin Endocrinol Metab. 1985, 60: 1019-1024.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR34","first-page":"1719","volume":"82","author":"NS Glaser","year":"1997","unstructured":"Glaser NS, Styne DM: Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab. 1997, 82: 1719-1726.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR35","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1542\/peds.2007-1535","volume":"121","author":"NS Glaser","year":"2008","unstructured":"Glaser NS, Styne DM: Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study. Pediatrics. 2008, 121: e481-e488.","journal-title":"Pediatrics"},{"key":"353_CR36","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1210\/jc.2008-0842","volume":"10","author":"F Kaguelidou","year":"2008","unstructured":"Kaguelidou F, Alberti C, Castanet M, Guitteny MA, Czernichow P, Leger J: Predictors of Autoimmune Hyperthyroidism Relapse in Children after Discontinuation of Antithyroid Drug Treatment. J Clin Endocrinol Metab. 2008, 10: 3817-3826.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1210\/jc.2011-1944","volume":"97","author":"J Leger","year":"2012","unstructured":"Leger J, Gelwane G, Kaguelidou F, Benmerad M, Alberti C: Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves' disease: national long-term cohort study. J Clin Endocrinol Metab. 2012, 97: 110-119.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncpendmet0068","volume":"2","author":"AP Weetman","year":"2006","unstructured":"Weetman AP: Graves' hyperthyroidism: how long should antithyroid drug therapy be continued to achieve remission?. Nat Clin Pract Endocrinol Metab. 2006, 2: 2-3.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"353_CR39","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1210\/jcem-70-3-675","volume":"70","author":"H Allannic","year":"1990","unstructured":"Allannic H, Fauchet R, Orgiazzi J, Madec AM, Genetet B, Lorcy Y, Le Guerrier AM, Delambre C, Derennes V: Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab. 1990, 70: 675-679.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR40","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/BF03348811","volume":"15","author":"RV Garcia-Mayor","year":"1992","unstructured":"Garcia-Mayor RV, Paramo C, Luna Cano R, Perez Mendez LF, Galofre JC, Andrade A: Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission. J Endocrinol Invest. 1992, 15: 815-820.","journal-title":"J Endocrinol Invest"},{"key":"353_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2265.1999.00629.x","volume":"50","author":"D Maugendre","year":"1999","unstructured":"Maugendre D, Gatel A, Campion L, Massart C, Guilhem I, Lorcy Y, Lescouarch J, Herry JY, Allannic H: Antithyroid drugs and Graves' disease\u2013prospective randomized assessment of long-term treatment. Clin Endocrinol (Oxf). 1999, 50: 127-132.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"353_CR42","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1089\/thy.1997.7.755","volume":"7","author":"DI Shulman","year":"1997","unstructured":"Shulman DI, Muhar I, Jorgensen EV, Diamond FB, Bercu BB, Root AW: Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid. 1997, 7: 755-760.","journal-title":"Thyroid"},{"key":"353_CR43","first-page":"CD006294","volume":"3","author":"C Ma","year":"2008","unstructured":"Ma C, Kuang A, Xie J, Liu G: Radioiodine treatment for pediatric Graves' disease. Cochrane Database Syst Rev. 2008, 3: CD006294-","journal-title":"Cochrane Database Syst Rev"},{"key":"353_CR44","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1210\/jcem-64-6-1241","volume":"64","author":"BM Lippe","year":"1987","unstructured":"Lippe BM, Landaw EM, Kaplan SA: Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. J Clin Endocrinol Metab. 1987, 64: 1241-1245.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR45","first-page":"1249","volume":"16","author":"L Gruneiro-Papendieck","year":"2003","unstructured":"Gruneiro-Papendieck L, Chiesa A, Finkielstain G, Heinrich JJ: Pediatric Graves' disease: outcome and treatment. J Pediatr Endocrinol Metab. 2003, 16: 1249-1255.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"353_CR46","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1210\/jcem.85.10.6922","volume":"85","author":"L Lazar","year":"2000","unstructured":"Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefsberg Z, Phillip M: Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab. 2000, 85: 3678-3682.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR47","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/thy.1997.7.369","volume":"7","author":"P Vitti","year":"1997","unstructured":"Vitti P, Rago T, Chiovato L, Pallini S, Santini F, Fiore E, Rocchi R, Martino E, Pinchera A: Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid. 1997, 7: 69-375.","journal-title":"Thyroid"},{"key":"353_CR48","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1210\/jcem-55-6-1138","volume":"55","author":"DJ Bouma","year":"1982","unstructured":"Bouma DJ, Kammer H, Greer MA: Follow-up comparison of short-term versus 1-year antithyroid drug therapy for the thyrotoxicosis of Graves' disease. J Clin Endocrinol Metab. 1982, 55: 1138-1142.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR49","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1056\/NEJM197707282970401","volume":"297","author":"MA Greer","year":"1977","unstructured":"Greer MA, Kammer H, Bouma DJ: Short-term antithyroid drug therapy for the thyrotoxicosis of Graves' disease. N Engl J Med. 1977, 297: 173-176.","journal-title":"N Engl J Med"},{"key":"353_CR50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/acta.0.1000221","volume":"100","author":"RF Bing","year":"1982","unstructured":"Bing RF: Early remission in thyrotoxicosis produced by short coursed of treatment. Acta Endocrinol Suppl. 1982, 100: 221-223.","journal-title":"Acta Endocrinol Suppl"},{"key":"353_CR51","doi-asserted-by":"publisher","first-page":"715","DOI":"10.7326\/0003-4819-137-9-200211050-00035","volume":"137","author":"SR Salpeter","year":"2002","unstructured":"Salpeter SR, Ormiston TM, Salpeter EE: Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med. 2002, 137: 715-725.","journal-title":"Ann Intern Med"},{"key":"353_CR52","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1515\/jpem.2011.032","volume":"24","author":"KA Wintergerst","year":"2011","unstructured":"Wintergerst KA, Rogers ES, Foster MB: Hyperthyroidism presenting with hyperglycemia in an adolescent female. J Pediatr Endocrinol Metab. 2011, 24: 385-387.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"353_CR53","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1399-5448.2012.00884.x","volume":"13","author":"MJ Gomez Cruz","year":"2012","unstructured":"Gomez Cruz MJ, Jabbar M, Saini N, Eng D, Crawford B, Vazquez DM, Menon R, Chen M: Severe hypoglycemia secondary to methimazole-induced insulin autoimmune syndrome in a 16\u00a0year old African-American male. Pediatr Diabetes. 2012, 13: 652-655.","journal-title":"Pediatr Diabetes"},{"key":"353_CR54","volume-title":"Int J Pediatr Endocrinol","author":"VC Benavides","year":"2010","unstructured":"Benavides VC, Rivkees SA: Myopathy associated with acute hypothyroidism following radioiodine therapy for graves disease in an adolescent. Int J Pediatr Endocrinol. 2010, 2010: doi:10.1155\/2010\/717303. Epub 2010 Sep 14"},{"key":"353_CR55","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1210\/jc.2011-1601","volume":"96","author":"NR van Veenendaal","year":"2011","unstructured":"van Veenendaal NR, Rivkees SA: Treatment of pediatric Graves' disease is associated with excessive weight gain. J Clin Endocrinol Metab. 2011, 96: 3257-3263.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR56","first-page":"421","volume-title":"The Thyroid","author":"ED Williams","year":"1986","unstructured":"Williams ED: Biological effects of radiation on the thyroid. The Thyroid. Edited by: Braverman LE, Utiger RD. 1986, Phildelphia: J.B. Lippincott Co, 421-436."},{"key":"353_CR57","doi-asserted-by":"publisher","first-page":"713","DOI":"10.4158\/EP10065.CO","volume":"16","author":"BE Hertz","year":"2010","unstructured":"Hertz BE, Schuller KE: Saul Hertz, Md (1905\u20131950): A Pioneer in the Use of Radioactive Iodine. Endocr Pract. 2010, 16: 713-715.","journal-title":"Endocr Pract"},{"key":"353_CR58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1210\/jcem-22-1-8","volume":"22","author":"GE Sheline","year":"1962","unstructured":"Sheline GE, McCormack KR, Galante M: Thyroid nodules occurring late after treatment of thryotoxicosis with radioiodine. J Clin Endocrinol Metab. 1962, 22: 8-17.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR59","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1210\/jcem-38-6-976","volume":"38","author":"BM Dobyns","year":"1974","unstructured":"Dobyns BM, Sheline GE, Workman JB, Tompkins EA, McConahey WM, Becker DV: Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. J Clin Endocrinol Metab. 1974, 38: 976-998.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR60","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1259\/0007-1285-36-425-340","volume":"36","author":"AWG Goolden","year":"1963","unstructured":"Goolden AWG, Davey JB: The ablation of normal thyroid tissue with iodine-131. Br J Radiol. 1963, 36: 340-345.","journal-title":"Br J Radiol"},{"key":"353_CR61","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJM198310203091601","volume":"309","author":"HR Maxon","year":"1983","unstructured":"Maxon HR, Thomas SR, Hertzberg VS, Kereiakes JG, Chen IW, Sperling MI, Saenger EL: Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med. 1983, 309: 937-941.","journal-title":"N Engl J Med"},{"key":"353_CR62","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3949\/ccjm.55.4.373","volume":"55","author":"WM Levy","year":"1988","unstructured":"Levy WM, Schumacher OP, Gupta M: Treatment of childhood Graves' disease. A review with emphasis on radioiodine treatment. Cleveland Clin J Med. 1988, 55: 373-382.","journal-title":"Cleveland Clin J Med"},{"key":"353_CR63","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1089\/thy.1997.7.247","volume":"7","author":"H Peters","year":"1997","unstructured":"Peters H, Fischer C, Bogner U, Reiners C, Schleusener H: Treatment of Graves' hyperthyroidism with radioiodine: results of a prospective randomized study. Thyroid. 1997, 7: 247-251.","journal-title":"Thyroid"},{"key":"353_CR64","doi-asserted-by":"publisher","first-page":"900","DOI":"10.7326\/0003-4819-105-6-900","volume":"105","author":"GD Graham","year":"1986","unstructured":"Graham GD, Burman KD: Radioiodine treatment of Graves' disease. An assessment of its potential risks. Ann Intern Med. 1986, 105: 900-905.","journal-title":"Ann Intern Med"},{"key":"353_CR65","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2362.1995.tb01547.x","volume":"25","author":"H Peters","year":"1995","unstructured":"Peters H, Fischer C, Bogner U, Reiners C, Schleusener H: Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131 iodine activity. Results from a prospective, randomized, multicentre study. Eur J Clin Invest. 1995, 25: 186-193.","journal-title":"Eur J Clin Invest"},{"key":"353_CR66","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0001-2998(71)81039-5","volume":"1","author":"DV Becker","year":"1971","unstructured":"Becker DV, Hurly JR: Complications of radioiodine treatment of hyperthyroidism. Semin Nucl Med. 1971, 1: 442-460.","journal-title":"Semin Nucl Med"},{"key":"353_CR67","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1210\/jcem.86.5.7473","volume":"86","author":"PM Kadmon","year":"2001","unstructured":"Kadmon PM, Noto RB, Boney CM, Goodwin G, Gruppuso PA: Thyroid storm in a child following radioactive iodine (RAI) therapy: a consequence of RAI versus withdrawal of antithyroid medication. J Clin Endocrinol Metab. 2001, 86: 1865-1867.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR68","first-page":"23","volume":"21","author":"S Refetoff","year":"1977","unstructured":"Refetoff S, Demeester-Mirkine N, Ermans AM, De Groot LJ: Rapid control of thyrotoxicosis with combined 131I, anthithyroid drugs and KI therapy. J Nucl Med Allied Sci. 1977, 21: 23-29.","journal-title":"J Nucl Med Allied Sci"},{"key":"353_CR69","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1210\/jcem-57-2-250","volume":"57","author":"DS Ross","year":"1983","unstructured":"Ross DS, Daniels GH, De Stefano P, Maloof F, Ridgway EC: Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves' hyperthyroidism. J Clin Endocrinol Metab. 1983, 57: 250-253.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR70","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/jama.1973.03220260030007","volume":"224","author":"B Rappaport","year":"1973","unstructured":"Rappaport B, Caplan R, De Groot LJ: Low-dose sodium iodine I 131 therapy in Graves disease. JAMA. 1973, 224: 1610-1613.","journal-title":"JAMA"},{"key":"353_CR71","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0002-9343(89)80485-1","volume":"87","author":"V Sridama","year":"1989","unstructured":"Sridama V, DeGroot LJ: Treatment of Graves' disease and the course of opthalmopathy. Am J of Med. 1989, 87: 70-73.","journal-title":"Am J of Med"},{"key":"353_CR72","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2265.1986.tb00765.x","volume":"24","author":"AW Goolden","year":"1986","unstructured":"Goolden AW, Stewart JS: Long-term results from graded low dose radioactive iodine therapy for thyrotoxicosis. Clin Endocrinol (Oxf). 1986, 24: 217-222.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"353_CR73","first-page":"538","volume":"72","author":"EP McCullagh","year":"1976","unstructured":"McCullagh EP, Jelden GL, Rodriguez-Antunez A: Incidence of hypothyroidism following small doses of 131I in the treatment of Graves' disease. Oh State Med J. 1976, 72: 538-540.","journal-title":"Oh State Med J"},{"issue":"94\u20137","key":"353_CR74","first-page":"122","volume":"58","author":"BM Dobyns","year":"1975","unstructured":"Dobyns BM: Radiation effects on the thyroid. Effects vary with dosage and sensitivity of the gland to radiation. RI Med J. 1975, 58 (94\u20137): 122-125.","journal-title":"RI Med J"},{"key":"353_CR75","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/archinte.1975.00330050047007","volume":"135","author":"AM Safa","year":"1975","unstructured":"Safa AM: Treatment of hyperthyroidism with a large initial dose of sodium iodine I 131. Arch Intern Med. 1975, 135: 673-675.","journal-title":"Arch Intern Med"},{"key":"353_CR76","first-page":"40","volume":"83","author":"L Chiovato","year":"1998","unstructured":"Chiovato L, Fiore E, Vitti P, Rocchi R, Rago T, Dokic D, Latrofa F, Mammoli C, Lippi F, Ceccarelli C, Pinchera A: Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. J Clin Endocrinol Metab. 1998, 83: 40-46.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR77","first-page":"3257","volume":"81","author":"Y Murakami","year":"1996","unstructured":"Murakami Y, Takamatsu J, Sakane S, Kuma K, Ohsawa N: Changes in thyroid volumes in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of throid-stimulatinf antibody and treatment outcome. J Clin Endocrinol Metab. 1996, 81: 3257-3260.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR78","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1046\/j.1365-2265.1997.2741075.x","volume":"47","author":"LD Hancock","year":"1997","unstructured":"Hancock LD, Tuttle RM, LeMar H, Baumen J, Patience T: The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease. Clin Endocrinol (Oxf). 1997, 47: 425-430.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"353_CR79","first-page":"3611","volume":"86","author":"A Allahabadia","year":"2001","unstructured":"Allahabadia A, Daykin J, Sheppard MC, Gough SC, Franklyn JA: Radioiodine treatment of hyperthyroidism-prognostic factors for outcome. J Clin Endocrinol Metab. 2001, 86: 3611-3617.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR80","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcu.1870180602","volume":"18","author":"D Ueda","year":"1990","unstructured":"Ueda D: Normal volume of the thyroid gland in children. J Clin Ultrasound. 1990, 18: 455-462.","journal-title":"J Clin Ultrasound"},{"key":"353_CR81","first-page":"600","volume":"79","author":"P Vitti","year":"1994","unstructured":"Vitti P, Martino E, Aghini-Lombardi F, Rago T, Antonangeli L, Maccherini D, Nanni P, Loviselli A, Balestrieri A, Araneo G: Thyroid volume measurement by ultrasound in children as a tool for the assessment of mild iodine deficiency. J Clin Endocrinol Metab. 1994, 79: 600-603.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR82","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1001\/archpedi.1965.02090030525002","volume":"110","author":"G Crile","year":"1965","unstructured":"Crile G, Schumacher OP: Radioactive iodine treatment of Graves' disease. Results in 32 children under 16\u00a0years of age. Am J Dis Child. 1965, 110: 501-504.","journal-title":"Am J Dis Child"},{"key":"353_CR83","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1056\/NEJM197010292831802","volume":"283","author":"A Hayek","year":"1970","unstructured":"Hayek A, Chapman EM, Crawford JD: Long term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine (131I) for hyperthyroidism. N Engl J Med. 1970, 283: 949-953.","journal-title":"N Engl J Med"},{"key":"353_CR84","first-page":"847","volume":"20","author":"JE Freitas","year":"1979","unstructured":"Freitas JE, Swanson DP, Gross MD, Sisson JC: Iodine131-I: optimal therapy for thyroidism in children and adolescents?. J Nucl Med. 1979, 20: 847-850.","journal-title":"J Nucl Med"},{"key":"353_CR85","first-page":"81","volume":"5","author":"P Starr","year":"1964","unstructured":"Starr P, Jaffe HL, Oettinger L: Late results of 131I treatment of hyperthyroidism in 73 children and adoloscents. J Nucl Med. 1964, 5: 81-89.","journal-title":"J Nucl Med"},{"key":"353_CR86","first-page":"586","volume":"10","author":"HJ Starr","year":"1969","unstructured":"Starr HJ, Oettinger L: Later results of 131-I treatment of hyperthyroidism in 73 children and adolescence: 1967 follow-up. J Nucl Med. 1969, 10: 586-590.","journal-title":"J Nucl Med"},{"key":"353_CR87","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJM196502042720501","volume":"272","author":"MD Kogut","year":"1965","unstructured":"Kogut MD, Kaplan SA, Collipp PJ, Tiamsic T, Boyle D: Treatment of hyperthyroidism in children: analysis of fourty-five patients. N Engl J Med. 1965, 272: 217-222.","journal-title":"N Engl J Med"},{"key":"353_CR88","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/00007611-199710000-00008","volume":"90","author":"GW Moll Jr","year":"1997","unstructured":"Moll GW, Patel BR: Pediatric Graves' Disease: therapeutic options and experinence with radioiodine at the University of Mississippi Medical center. South Med J. 1997, 90: 1017-","journal-title":"South Med J"},{"key":"353_CR89","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1056\/NEJM197501232920401","volume":"292","author":"AM Safa","year":"1975","unstructured":"Safa AM, Schumacher OP, Rodriguez-Antunez A: Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism. N Engl J Med. 1975, 292: 167-171.","journal-title":"N Engl J Med"},{"key":"353_CR90","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1542\/peds.111.4.745","volume":"111","author":"SA Rivkees","year":"2003","unstructured":"Rivkees SA, Cornelius EA: Influence of iodine-131 dose on the outcome of hyperthyroidism in children. Pediatrics. 2003, 111: 745-749.","journal-title":"Pediatrics"},{"key":"353_CR91","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1067\/mpd.2002.125494","volume":"141","author":"TD Nebesio","year":"2002","unstructured":"Nebesio TD, Siddiqui AR, Pescovitz OH, Eugster EA: Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children. J Pediatr. 2002, 141: 99-103.","journal-title":"J Pediatr"},{"key":"353_CR92","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1210\/jc.2002-021801","volume":"88","author":"JE Kalinyak","year":"2003","unstructured":"Kalinyak JE, McDougall IR: How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism?. J Clin Endocrinol Metab. 2003, 88: 975-977.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR93","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1210\/jc.2002-020805","volume":"88","author":"WD Leslie","year":"2003","unstructured":"Leslie WD, Ward L, Salamon EA, Ludwig S, Rowe RC, Cowden EA: A randomized comparison of radioiodine doses in Graves' hyperthyroidism. J Clin Endocrinol Metab. 2003, 88: 978-983.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR94","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0022-3476(77)80843-3","volume":"91","author":"HV Barnes","year":"1977","unstructured":"Barnes HV, Blizzard RM: Antithyroid drug therapy for toxic diffuse goiter (Graves disease): thirty years experience in children and adolscence. J Pediatr. 1977, 91: 313-320.","journal-title":"J Pediatr"},{"key":"353_CR95","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S0039-6060(96)80049-3","volume":"120","author":"P Miccoli","year":"1996","unstructured":"Miccoli P, Vitti P, Rago T, Iacconi P, Bartalena L, Bogazzi F, Fiore E, Valeriano R, Chiovato L, Rocchi R, Pinchera A: Surgical treatment of Graves' disease: subtotal or total thyroidectomy?. Surgery. 1996, 120: 1020-1024. discussion 4\u20135","journal-title":"Surgery"},{"key":"353_CR96","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S1043-2760(02)00622-7","volume":"13","author":"WM Wiersinga","year":"2002","unstructured":"Wiersinga WM, Prummel MF: Graves' ophthalmopathy: A rational approach to treatment. Trends Endocrinol Metab. 2002, 13: 280-287.","journal-title":"Trends Endocrinol Metab"},{"key":"353_CR97","first-page":"460","volume":"17","author":"SD Sarkar","year":"1976","unstructured":"Sarkar SD, Beierwaltes WH, Gill SP, Cowley BJ: Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer. J Nucl Med. 1976, 17: 460-464.","journal-title":"J Nucl Med"},{"key":"353_CR98","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/jnci\/dji151","volume":"97","author":"JD Boice Jr","year":"2005","unstructured":"Boice JD: Radiation-induced thyroid cancer\u2013what's new?. J Natl Cancer Inst. 2005, 97: 703-705.","journal-title":"J Natl Cancer Inst"},{"key":"353_CR99","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/jama.295.9.1060","volume":"295","author":"JD Boice Jr","year":"2006","unstructured":"Boice JD: Thyroid disease 60\u00a0years after Hiroshima and 20\u00a0years after Chernobyl. JAMA. 2006, 295: 1060-1062.","journal-title":"JAMA"},{"key":"353_CR100","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2307\/3579003","volume":"141","author":"E Ron","year":"1995","unstructured":"Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD: Thyroid Cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995, 141: 259-277.","journal-title":"Radiat Res"},{"key":"353_CR101","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00004032-196809000-00002","volume":"15","author":"GW Dolphin","year":"1968","unstructured":"Dolphin GW: The risk of thyroid cancers following irradiation. Health Phys. 1968, 15: 219-228.","journal-title":"Health Phys"},{"key":"353_CR102","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/S0140-6736(05)66695-0","volume":"365","author":"AJ Sigurdson","year":"2005","unstructured":"Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, Berkow RL, Hammond S, Neglia JP, Meadows AT, Sklar CA, Robison LL, Inskip PD: Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case\u2013control study. Lancet. 2005, 365: 2014-2023.","journal-title":"Lancet"},{"key":"353_CR103","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1210\/jc.2005-1833","volume":"91","author":"RW Flynn","year":"2006","unstructured":"Flynn RW, Macdonald TM, Jung RT, Morris AD, Leese GP: Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab. 2006, 91: 2159-2164.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR104","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJM199803123381103","volume":"338","author":"JA Franklyn","year":"1998","unstructured":"Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J, Boyle P: Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med. 1998, 338: 712-718.","journal-title":"N Engl J Med"},{"key":"353_CR105","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.294.1.71","volume":"294","author":"JA Franklyn","year":"2005","unstructured":"Franklyn JA, Sheppard MC, Maisonneuve P: Thyroid function and mortality in patients treated for hyperthyroidism. JAMA. 2005, 294: 71-80.","journal-title":"JAMA"},{"key":"353_CR106","first-page":"2283","volume":"50","author":"MB Goldman","year":"1990","unstructured":"Goldman MB, Monson RR, Maloof F: Cancer mortality in women with thyroid disease. Cancer Res. 1990, 50: 2283-2289.","journal-title":"Cancer Res"},{"key":"353_CR107","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/jnci\/83.15.1072","volume":"83","author":"LE Holm","year":"1991","unstructured":"Holm LE, Hall P, Wiklund K, Lundell G, Berg G, Bjelkengren G, Cederquist E, Ericsson UB, Hallquist A, Larsson LG: Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst. 1991, 83: 1072-1077.","journal-title":"J Natl Cancer Inst"},{"key":"353_CR108","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1210\/jc.2006-2321","volume":"92","author":"S Metso","year":"2007","unstructured":"Metso S, Jaatinen P, Huhtala H, Auvinen A, Oksala H, Salmi J: Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. J Clin Endocrinol Metab. 2007, 92: 2190-2196.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR109","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/jama.280.4.347","volume":"280","author":"E Ron","year":"1998","unstructured":"Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, Harris BS, Hoffman DA, McConahey WM, Maxon HR, Preston-Martin S, Warshauer ME, Wong FL, Boice JD: Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA. 1998, 280: 347-355.","journal-title":"JAMA"},{"issue":"9","key":"353_CR110","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1210\/jc.2003-031223","volume":"89","author":"CH Read Jr","year":"2004","unstructured":"Read CH, Tansey MJ, Menda Y: A thirty-six year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' pateints. JCEM. 2004, 89 (9): 4229-4233.","journal-title":"JCEM"},{"key":"353_CR111","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1148\/radiographics.20.2.g00mc33533","volume":"20","author":"RE Toohey","year":"2000","unstructured":"Toohey RE, Stabin MG, Watson EE: The AAPM\/RSNA physics tutorial for residents: internal radiation dosimetry: principles and applications. Radiographics. 2000, 20: 533-546.","journal-title":"Radiographics"},{"key":"353_CR112","first-page":"532","volume-title":"Proceedings of the Sixth International Radiopharmaceutical Dosimetry Symposium","author":"RE Toohey","year":"1996","unstructured":"Toohey RE, Stabin MG: Comparative analysis of dosimetry parameters for nuclear medicine. ORISE Report 99\u20131064, 1999. Proceedings of the Sixth International Radiopharmaceutical Dosimetry Symposium. 1996, Gatlinburg, TN, 532-551."},{"key":"353_CR113","unstructured":"Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII \u2013 Phase 2. 2006, Washington D.C: National Academies Press"},{"key":"353_CR114","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1001\/archotol.1977.00780260074010","volume":"103","author":"T Ching","year":"1977","unstructured":"Ching T, Warden MJ, Fefferman RA: Thyroid surgery in children and teenagers. Arch Otolaryngol. 1977, 103: 544-546.","journal-title":"Arch Otolaryngol"},{"key":"353_CR115","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1001\/archpedi.1981.02130260004003","volume":"135","author":"BA Buckingham","year":"1981","unstructured":"Buckingham BA, Costin G, Roe TF, Weitzman JJ, Kogut MD: Hyperthyroidism in children. A reevaluation of treatment. Am J Dis Child. 1981, 135: 112-117.","journal-title":"Am J Dis Child"},{"key":"353_CR116","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1530\/eje.0.1340710","volume":"134","author":"C Rudberg","year":"1996","unstructured":"Rudberg C, Johansson H, Akerstrom G, Tuvemo T, Karlsson FA: Graves' disease in children and adolescents. Late results of surgical treatment. Eur J Endocrinol\/Eur Fed Endocr Soc. 1996, 134: 710-715.","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"key":"353_CR117","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1046\/j.1365-2362.1996.98243.x","volume":"26","author":"H Peters","year":"1996","unstructured":"Peters H, Fischer C, Bogner U, Reiners C, Schleusener H: Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: results of a prospective, randomized, multicentre study. Eur J Clin Invest. 1996, 26: 59-63.","journal-title":"Eur J Clin Invest"},{"key":"353_CR118","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1210\/jc.2008-0660","volume":"93","author":"JA Sosa","year":"2008","unstructured":"Sosa JA, Tuggle CT, Wang TS, Thomas DC, Boudourakis L, Rivkees S, Roman SA: Clinical and economic outcomes of thyroid and parathyroid surgery in children. J Clin Endocrinol Metab. 2008, 93: 3058-3065.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1687-9856-2013-1","volume":"2013","author":"CK Breuer","year":"2013","unstructured":"Breuer CK, Solomon D, Donovan P, Rivkees SA, Udelsman R: Effect of patient Age on surgical outcomes for Graves' disease: a case\u2013control study of 100 consecutive patients at a high volume thyroid surgical center. Int J Pediatr Endocrinol. 2013, 2013: 1-","journal-title":"Int J Pediatr Endocrinol"},{"key":"353_CR120","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1089\/thy.2005.15.569","volume":"15","author":"G Lal","year":"2005","unstructured":"Lal G, Ituarte P, Kebebew E, Siperstein A, Duh QY, Clark OH: Should total thyroidectomy become the preferred procedure for surgical management of Graves' disease?. Thyroid. 2005, 15: 569-574.","journal-title":"Thyroid"},{"key":"353_CR121","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.suc.2004.01.006","volume":"84","author":"MS Boger","year":"2004","unstructured":"Boger MS, Perrier ND: Advantages and disadvantages of surgical therapy and optimal extent of thyroidectomy for the treatment of hyperthyroidism. Surg Clin N Am. 2004, 84: 849-874.","journal-title":"Surg Clin N Am"},{"key":"353_CR122","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s002680010216","volume":"24","author":"J Witte","year":"2000","unstructured":"Witte J, Goretzki PE, Dotzenrath C, Simon D, Felis P, Neubauer M, R\u00f6her HD: Surgery for Graves' disease: total versus subtotal thyroidectomy-results of a prospective randomized trial. World J Surg. 2000, 24: 1303-1311.","journal-title":"World J Surg"},{"key":"353_CR123","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/00000658-199809000-00005","volume":"228","author":"JA Sosa","year":"1998","unstructured":"Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R: The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg. 1998, 228: 320-330.","journal-title":"Ann Surg"},{"issue":"Suppl 1","key":"353_CR124","first-page":"79","volume":"5","author":"C Breuer","year":"2013","unstructured":"Breuer C, Tuggle C, Solomon D, Sosa JA: Pediatric thyroid disease: when is surgery necessary, and who should be operating on our children?. J Clin Res Pediatr Endocrinol. 2013, 5 (Suppl 1): 79-85.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"353_CR125","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00383-012-3095-5","volume":"28","author":"E Peroni","year":"2012","unstructured":"Peroni E, Angiolini MR, Vigone MC, Mari G, Chiumello G, Beretta E, Weber G: Surgical management of pediatric Graves' disease: an effective definitive treatment. Pediatr Surg Int. 2012, 28: 609-614.","journal-title":"Pediatr Surg Int"},{"key":"353_CR126","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1210\/jc.2003-031223","volume":"89","author":"CH Read Jr","year":"2004","unstructured":"Read CH, Tansey MJ, Menda Y: A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. J Clin Endocrinol Metab. 2004, 89: 4229-4233.","journal-title":"J Clin Endocrinol Metab"},{"key":"353_CR127","first-page":"141","volume-title":"The Diaganosis and Treatment of Endocrine Disorders in Children and Adolescence. Hypothyroidism","author":"L Wilkins","year":"1965","unstructured":"Wilkins L: The Diaganosis and Treatment of Endocrine Disorders in Children and Adolescence. Hypothyroidism. 1965, Charles Thomas, Springfield, 141-150."},{"key":"353_CR128","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1210\/jcem.83.11.5056-1","volume":"83","author":"T Davies","year":"1998","unstructured":"Davies T, Roti E, Braverman LE, De Groot LJ: Thyroid conterversy\u2013stimulating antibodies. J Clin Endocrinol Metab. 1998, 83: 3777-3785.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"353_CR129","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1365-2265.1986.tb01676.x","volume":"25","author":"R Wilson","year":"1986","unstructured":"Wilson R, McKilop JH, Henderson N, Pearson DW, Thomson JA: The ability of the serum throtrophin receptr antibody (TRAb) index and HLA status to predict long-term remission of thyrotoxicosis following medical therapy for Graves' disease. Clin Endocrinol (Oxf). 1986, 25 (2): 151-156.","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["International Journal of Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1687-9856-2014-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T01:46:38Z","timestamp":1597974398000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijpeonline.biomedcentral.com\/articles\/10.1186\/1687-9856-2014-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,16]]},"references-count":129,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1186\/1687-9856-2014-10","relation":{},"ISSN":["1687-9856"],"issn-type":[{"value":"1687-9856","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,16]]},"assertion":[{"value":"10 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"10"}}